Detalhe da pesquisa
1.
Intravenous Vancomycin Associated With the Development of Nephrotoxicity in Patients With Class III Obesity.
Ann Pharmacother
; 51(11): 937-944, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28709394
2.
The Penn Medicine COVID-19 Therapeutics Committee-Reflections on a Model for Rapid Evidence Review and Dynamic Practice Recommendations During a Public Health Emergency.
Open Forum Infect Dis
; 10(8): ofad428, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37663091
3.
Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa.
Open Forum Infect Dis
; 8(8): ofab371, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34430671
4.
Assessing an intervention to improve the safety of automatic stop orders for inpatient antimicrobials.
Infect Prev Pract
; 2(2): 100062, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34368705
5.
Real-world Multicenter Analysis of Clinical Outcomes and Safety of Meropenem-Vaborbactam in Patients Treated for Serious Gram-Negative Bacterial Infections.
Open Forum Infect Dis
; 7(3): ofaa051, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32161775